AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 184 filers reported holding AXSOME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $551,851 | -19.1% | 7,896 | -16.8% | 0.01% | -28.6% |
| Q2 2023 | $681,808 | +12.8% | 9,488 | -3.2% | 0.01% | 0.0% |
| Q1 2023 | $604,587 | -3.0% | 9,802 | +21.3% | 0.01% | +16.7% |
| Q4 2022 | $623,442 | -99.9% | 8,083 | -60.4% | 0.01% | +20.0% |
| Q3 2022 | $456,456,000 | +83961.9% | 20,434 | +44.2% | 0.01% | -16.7% |
| Q2 2022 | $543,000 | +36.8% | 14,169 | +47.7% | 0.01% | +50.0% |
| Q1 2022 | $397,000 | +68.2% | 9,595 | +53.4% | 0.00% | +100.0% |
| Q4 2021 | $236,000 | +12.4% | 6,254 | -2.0% | 0.00% | 0.0% |
| Q3 2021 | $210,000 | -44.4% | 6,384 | +14.0% | 0.00% | -50.0% |
| Q2 2021 | $378,000 | +68.0% | 5,600 | +41.0% | 0.00% | +33.3% |
| Q1 2021 | $225,000 | – | 3,973 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
| MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
| Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
| WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
| Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
| RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
| MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
| Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
| Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |